TATVA CHINTAN PHARMA CHEM Financial Statement Analysis
|
||
|
The Revenues of TATVA CHINTAN PHARMA CHEM have increased by 32.18% YoY .
The Earnings Per Share (EPS) of TATVA CHINTAN PHARMA CHEM has increased by 636.89 % YoY. |
||
TATVA CHINTAN PHARMA CHEM Last 5 Annual Financial Results
[BOM: 543321|NSE : TATVA]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹506 Cr | ₹383 Cr | ₹394 Cr | ₹424 Cr | ₹434 Cr |
| Expenses | ₹412 Cr | ₹348 Cr | ₹325 Cr | ₹363 Cr | ₹325 Cr |
| Operating Profit (Excl OI) | ₹93 Cr | ₹34 Cr | ₹68 Cr | ₹61 Cr | ₹109 Cr |
| Other Income | ₹3.55 Cr | ₹2.32 Cr | ₹7.51 Cr | ₹5.74 Cr | ₹9.02 Cr |
| Interest | ₹3.14 Cr | ₹1.51 Cr | ₹6.73 Cr | ₹8.60 Cr | ₹5.23 Cr |
| Depreciation | ₹37 Cr | ₹28 Cr | ₹26 Cr | ₹9.56 Cr | ₹8.18 Cr |
| Profit Before Tax | ₹57 Cr | ₹7.58 Cr | ₹44 Cr | ₹45 Cr | ₹104 Cr |
| Profit After Tax | ₹42 Cr | ₹5.71 Cr | ₹30 Cr | ₹45 Cr | ₹96 Cr |
| Consolidated Net Profit | ₹42 Cr | ₹5.71 Cr | ₹30 Cr | ₹45 Cr | ₹96 Cr |
| Earnings Per Share (Rs) | ₹17.98 | ₹2.44 | ₹12.98 | ₹20.52 | ₹43.25 |
| PAT Margin (%) | 8.30 | 1.49 | 7.69 | 10.73 | 22.10 |
| ROE(%) | 5.53 | 0.77 | 4.85 | 9.21 | 30.01 |
| ROCE(%) | 7.17 | 1.19 | 7.00 | 8.35 | 25.75 |
| Total Debt/Equity(x) | 0.15 | 0.05 | 0.02 | 0.33 | 0.25 |
Key Financials |
||
| Market Cap | : | ₹ 4,087.5 Cr |
| Revenue (TTM) | : | ₹ 556.0 Cr |
| Net Profit(TTM) | : | ₹ 51.4 Cr |
| EPS (TTM) | : | ₹ 22.0 |
| P/E (TTM) | : | 79.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| TATVA CHINTAN PHARMA CHEM | -2.5% | 8.8% | 68.3% |
| SOLAR INDUSTRIES INDIA | -1.8% | -3.2% | 38% |
| PIDILITE INDUSTRIES | -2.7% | -10.6% | -1.7% |
| SRF | -1.6% | -3.6% | -13.9% |
| GUJARAT FLUOROCHEMICALS | -2.2% | -8.4% | 16.5% |
| GODREJ INDUSTRIES | -7.5% | -11.5% | -14.5% |
| NAVIN FLUORINE INTERNATIONAL | -5.2% | -5.8% | 73.4% |
| DEEPAK NITRITE | -5.9% | -16.3% | -17.8% |
| ATUL | -3.6% | -9.2% | -4.7% |
TATVA CHINTAN PHARMA CHEM Revenues
[BOM: 543321|NSE : TATVA]
| Y-o-Y | 32.18 % |
| 5 Yr CAGR | 3.93 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹506 Cr | 32.18 | |
| Mar2025 | ₹383 Cr | -2.74 | |
| Mar2024 | ₹394 Cr | -7.11 | |
| Mar2023 | ₹424 Cr | -2.31 | |
| Mar2022 | ₹434 Cr | - | |
TATVA CHINTAN PHARMA CHEM Operating Profit
[BOM: 543321|NSE : TATVA]
| Y-o-Y | 171.37 % |
| 5 Yr CAGR | -3.67 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹93 Cr | 171.37 | |
| Mar2025 | ₹34 Cr | -49.65 | |
| Mar2024 | ₹68 Cr | 12.53 | |
| Mar2023 | ₹61 Cr | -43.99 | |
| Mar2022 | ₹109 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 105.22 % |
| 5 Yr CAGR | -7.31 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 18.47% | 105.22 | |
| Mar2025 | 9% | -48.22 | |
| Mar2024 | 17.38% | 21.11 | |
| Mar2023 | 14.35% | -42.65 | |
| Mar2022 | 25.02% | - | |
TATVA CHINTAN PHARMA CHEM Profit After Tax
[BOM: 543321|NSE : TATVA]
| Y-o-Y | 636.11 % |
| 5 Yr CAGR | -18.62 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹42 Cr | 636.11 | |
| Mar2025 | ₹5.71 Cr | -81.18 | |
| Mar2024 | ₹30 Cr | -33.27 | |
| Mar2023 | ₹45 Cr | -52.56 | |
| Mar2022 | ₹96 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 457.05 % |
| 5 Yr CAGR | -21.72 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 8.3 % | 457.05 | |
| Mar2025 | 1.49 % | -80.62 | |
| Mar2024 | 7.69 % | -28.33 | |
| Mar2023 | 10.73 % | -51.45 | |
| Mar2022 | 22.1 % | - | |
TATVA CHINTAN PHARMA CHEM Earnings Per Share (EPS)
[BOM: 543321|NSE : TATVA]
| Y-o-Y | 636.89 % |
| 5 Yr CAGR | -19.70 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹18 | 636.89 | |
| Mar2025 | ₹2.44 | -81.20 | |
| Mar2024 | ₹13 | -36.74 | |
| Mar2023 | ₹21 | -52.55 | |
| Mar2022 | ₹43 | - | |
TATVA CHINTAN PHARMA CHEM Return on Capital Employed (ROCE)
[BOM: 543321|NSE : TATVA]
| Y-o-Y | 502.52 % |
| 5 Yr CAGR | -27.36 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 7.17% | 502.52 | |
| Mar2025 | 1.19% | -83.00 | |
| Mar2024 | 7% | -16.17 | |
| Mar2023 | 8.35% | -67.57 | |
| Mar2022 | 25.75% | - | |
TATVA CHINTAN PHARMA CHEM Share Price vs Sensex
| Current Share Price | : | ₹1,746.8 |
| Current MarketCap | : | ₹ 4,087.5 Cr |
| Updated EOD on | : | Oct 01,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TATVA CHINTAN PHARMA CHEM | -2.5% |
8.8% |
68.3% |
| SENSEX | -2.3% |
-6.6% |
-12% |
TATVA CHINTAN PHARMA CHEM related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 1000 | -2.9% | -6.2% | -5% |
| BSE COMMODITIES | -4.1% | -6.1% | 1.8% |
No NSE index found
You may also like the below Video Courses
FAQ about TATVA CHINTAN PHARMA CHEM Financials
How the annual revenues of TATVA CHINTAN PHARMA CHEM have changed ?
The Revenues of TATVA CHINTAN PHARMA CHEM have increased by 32.18% YoY .
How the Earnings per Share (EPS) of TATVA CHINTAN PHARMA CHEM have changed?
The Earnings Per Share (EPS) of TATVA CHINTAN PHARMA CHEM has increased by 636.89 % YoY .
Check out Intrinsic Value of Peers of TATVA CHINTAN PHARMA CHEM
Compare Stock Analytics of Peers of TATVA CHINTAN PHARMA CHEM
SOLAR INDUSTRIES INDIA LTD vs PIDILITE INDUSTRIES LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs GODREJ INDUSTRIES LTD vs
SOLAR INDUSTRIES INDIA LTD vs PIDILITE INDUSTRIES LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs GODREJ INDUSTRIES LTD vs
